Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2021
Novel adjuvant options for cutaneous melanomaF Dimitriou, G V Long, A M MenziesBritish Journal of Cancer|December 9, 2010
Targeting BRAF for patients with melanomaH-T Arkenau, R Kefford, G V LongJournal of Medicinal Chemistry|October 15, 1993
Solution conformation of the antitumor drug streptonigrinM M Harding, G V Long, C L BrownAnti-Cancer Drug Design|October 6, 1997
Interaction of the antitumour antibiotic streptonigrin with DNA and oligonucleotidesG V Long, M M Harding, J Y Fan, et al.The British Journal of Surgery|January 18, 2018
Impact of genomics on the surgical management of melanomaP M Ferguson, G V Long, R A Scolyer, et al.Respiratory Medicine Case Reports|November 8, 2021
Acute bilateral phrenic nerve neuropathy causing hypercapnic respiratory associated with checkpoint inhibitor immunotherapyM Srinivasan, A M Taylor, G V Long, et al.The British Journal of Dermatology|July 23, 2013
Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitorsR Anforth, T C M P Blumetti, A Clements, et al.ESMO Open|June 21, 2025
Do BRAF-targeted therapies have a role in the era of immunotherapy?J Braden, J W Conway, J S Wilmott, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2021
FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanomaF Dimitriou, S N Lo, A C Tan, et al.Cell Death & Disease|November 9, 2013
AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanomaW Hu, L Jin, C C Jiang, et al.Pageof 6